Workshops
CellFit Project workshops seek to address one of the biggest challenges for cell-based cancer therapy – efficient and scalable production.
Cell Therapy Innovation Symposium 2025
08.10.2025 - Oslo
Thermo Fisher Scientific & Oslo Cancer Cluster, together with the CellFit Project invites you to join the Cell Therapy Innovation Symposium to explore the challenges and innovative solutions in immune cell therapy manufacturing. This symposium will engage experts and professionals involved in the design and manufacturing of immune cell therapies, including process developers, scientist, and lab managers.
A special feature will include a tour of OCC Innovation Park to highlight the recent expansion of this vibrant park anchored by Radium Hospital. The John Ugelstad building is under construction and expected to be completed by the end of 2025. The symposium’s organizing team will track the building progress and if possible, plan a tour (from inside or outside pending approvals).
About the co-organizer: Established in 2021, the CellFit Project is funded by The Research Council of Norway, a project led by Oslo University Hospital with project partners Oslo Cancer Cluster, SINTEF, and Thermo Fisher Scientific. The aim of the project is to improve the fitness of CAR T Cells by optimizing the manufacturing process.
PROGRAM (program with additional speakers will be released by September, 2025)
Workshop 17.06.2025 - Oslo
Enabling Technologies & Accelerating Research to Improve T cells to Fight Cancer
Welcome & The CellFit Project, A Status Update
Else Marit Inderberg, PhD, Unit Leader, Translational Research Unit,
Section for Cell Therapy, Department of Oncology, Oslo University Hospital
High-throughput screening to identify compounds that affect the T-cell subtype during expansion
Hanne Haslene-Hox, PhD, Senior Research Scientist, SINTEF
How to generate less differentiated, more persistent CAR T cells
Léa Rosselle, PhD, Translational Research Unit, Section for Cell Therapy,
Department of Oncology,Oslo University Hospital
A streamlined automated solution for CAR-T Manufacturing using CTS™ Detachable Dynabeads™
Maxi-Lu Böschen, Scientist III R&D Cell Therapy, Thermo Fisher Scientific
Support functions available at the ACT Centre
Anna Pasetto, Director of the Center for Advanced Cell Therapy (ACT), Section for Cell Therapy,
Division for Cancer Treatment, Cancer Clinic, Oslo University Hospital, Associate Professor,
Institute of Clinical Medicine, Division of Cancer Medicine, University of Oslo
Next steps and a way forward – Closing Remarks
Else Marit Inderberg, PhD, Unit Leader, Translational Research Unit,
Section for Cell Therapy, Department of Oncology, Oslo University Hospital
Workshop 15.02.2023 - Oslo
Welcome and Introduction to The CellFit Project
Else Marit Inderberg, PhD, Senior Scientist, Group Leader, Head of Immunomonitoring,
Department of Oncology, Cellular Therapy, Oslo University Hospital
Transitioning from a benchtop to a clinical manufacturing workflow
Evan Zynda, Sr Scientist R&D Cell Therapy, Thermo Fisher Scientific (Digital Talk)
Efficient process development with miniaturized systems.
Hanne Haslene-Hox, PhD, Senior Research Scientist, SINTEF
Oslo University Hospital Update – Screening for the optimal therapeutic cell
Léa Rosselle, PhD, and Fatemeh Kaveh, PhD, Oslo University Hospital
Workshop 10.10.2023 - Trondheim
Welcome and Introduction to The CellFit Project
Hanne Haslene-Hox, PhD, Senior Research Scientist, SINTEF
Immune receptor development platforms: Novel and unexpected targets for CAR T-cell therapy
Else Marit Inderberg, PhD, Senior Scientist, Group Leader, Head of Immunomonitoring,
Department of Oncology, Cellular Therapy, Oslo University Hospital
Centre for Advanced Cell Therapy:
A new support infrastructure for the early steps of cell therapy development
Anna Pasetto, PhD, Director of the Center for Advanced Cell Therapy (ACT), Section for Cell Therapy, Division for Cancer Treatment, Cancer Clinic, Oslo University Hospital Associate Professor, Institute of Clinical Medicine, Division of Cancer Medicine, University of Oslo
Tumor-on-a-chip: using microfluidic devices to understand the interaction between tumor and immune cells (Digital)
Lucia Gabriele, PhD, Head of Immuno-Oncology Section, Dept. OMM, ISS, Rome
Closing remarks by
Hanne Haslene-Hox, PhD, Senior Research Scientist, SINTEF